Cargando…

The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice

The beneficial effects of probiotics on immune-based pathologies such as inflammatory bowel disease (IBD) have been well reported. However, their exact mechanisms have not been fully elucidated. Few studies have focused on the impact of probiotics on the composition of the colonic microbiota. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Nogales, Alba, Algieri, Francesca, Garrido-Mesa, José, Vezza, Teresa, Utrilla, Maria P., Chueca, Natalia, Fernández-Caballero, Jose A., García, Federico, Rodríguez-Cabezas, Maria E., Gálvez, Julio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958303/ https://www.ncbi.nlm.nih.gov/pubmed/29867475 http://dx.doi.org/10.3389/fphar.2018.00468

Ejemplares similares

Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice
por: Fábrega, María-José, et al.
Publicado: (2017)

Antinociceptive and Anti-Inflammatory Effects of Total Alkaloid Extract from Fumaria capreolata
por: Bribi, Noureddine, et al.
Publicado: (2015)

Calcium Pyruvate Exerts Beneficial Effects in an Experimental Model of Irritable Bowel Disease Induced by DCA in Rats
por: Rodríguez-Nogales, Alba, et al.
Publicado: (2019)

Flavonoids in Inflammatory Bowel Disease: A Review
por: Vezza, Teresa, et al.
Publicado: (2016)

Effect of a Ropy Exopolysaccharide-Producing Bifidobacterium animalis subsp. lactis Strain Orally Administered on DSS-Induced Colitis Mice Model
por: Hidalgo-Cantabrana, Claudio, et al.
Publicado: (2016)

Intestinal anti-inflammatory effects of RGD-functionalized silk fibroin nanoparticles in trinitrobenzenesulfonic acid-induced experimental colitis in rats
por: Rodriguez-Nogales, Alba, et al.
Publicado: (2016)

Intestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in rats
por: Ruiz-Malagón, Antonio Jesús, et al.
Publicado: (2022)

Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model
por: Park, Jihye, et al.
Publicado: (2021)

Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats
por: Lozano-Pérez, Antonio Abel, et al.
Publicado: (2014)

Quorum sensing in the probiotic bacterium Escherichia coli Nissle 1917 (Mutaflor) – evidence that furanosyl borate diester (AI-2) is influencing the cytokine expression in the DSS colitis mouse model
por: Jacobi, Christoph A, et al.
Publicado: (2012)

Probiotic and Functional Properties of Limosilactobacillus reuteri INIA P572
por: Diez-Echave, Patricia, et al.
Publicado: (2021)

Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
por: Yu, Xiaoli, et al.
Publicado: (2019)

Protocol for engineering E. coli Nissle 1917 to diagnose, record, and ameliorate inflammatory bowel disease in mice
por: Zou, Zhen-Ping, et al.
Publicado: (2023)

Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review
por: Algieri, Francesca, et al.
Publicado: (2015)

Synergic Interaction of Rifaximin and Mutaflor (Escherichia coli Nissle 1917) in the Treatment of Acetic Acid-Induced Colitis in Rats
por: Dembiński, Artur, et al.
Publicado: (2016)

Gradient Magnetic Field Accelerates Division of E. coli Nissle 1917
por: Gorobets, Svitlana, et al.
Publicado: (2023)

Intestinal anti-inflammatory effects of goat whey on DNBS-induced colitis in mice
por: Araújo, Daline F. S., et al.
Publicado: (2017)

Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders
por: Gómez-Guzmán, Manuel, et al.
Publicado: (2018)

Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
por: Pérez-Berezo, Teresa, et al.
Publicado: (2017)

Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917
por: Massip, Clémence, et al.
Publicado: (2019)

Escherichiacoli Nissle 1917 as a Novel Microrobot for Tumor-Targeted Imaging and Therapy
por: Liu, Qingyao, et al.
Publicado: (2021)

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)
por: Matthes, Harald, et al.
Publicado: (2010)

The secreted autotransporter toxin (Sat) does not act as a virulence factor in the probiotic Escherichia coli strain Nissle 1917
por: Toloza, Lorena, et al.
Publicado: (2015)

Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
por: Ukena, Sya N., et al.
Publicado: (2007)

E. coli Nissle 1917 Affects Salmonella Adhesion to Porcine Intestinal Epithelial Cells
por: Schierack, Peter, et al.
Publicado: (2011)

The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ
por: Bury, Susanne, et al.
Publicado: (2018)

Engineered E. coli Nissle 1917 for the reduction of vancomycin‐resistant Enterococcus in the intestinal tract
por: Geldart, Kathryn G., et al.
Publicado: (2018)

Effects of Escherichia coli strain Nissle 1917 on exercise-induced disruption of gastrointestinal integrity
por: Mooren, F. C., et al.
Publicado: (2020)

Transcriptional Profiling of the Probiotic Escherichia coli Nissle 1917 Strain under Simulated Microgravity
por: Yim, Jaewoo, et al.
Publicado: (2020)

Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
por: Praveschotinunt, Pichet, et al.
Publicado: (2019)

No Genotoxicity Is Detectable for Escherichia coli Strain Nissle 1917 by Standard In Vitro and In Vivo Tests
por: Dubbert, Silke, et al.
Publicado: (2020)

Plasmid Vectors for in Vivo Selection-Free Use with the Probiotic E. coli Nissle 1917
por: Kan, Anton, et al.
Publicado: (2020)

Escherichia coli Nissle 1917 inhibits biofilm formation and mitigates virulence in Pseudomonas aeruginosa
por: Aljohani, Ahmad M., et al.
Publicado: (2023)

Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy
por: Tumas, Sarunas, et al.
Publicado: (2023)

Exploring the Role of CYP3A4 Mediated Drug Metabolism in the Pharmacological Modulation of Nitric Oxide Production
por: Pérez-del Palacio, José, et al.
Publicado: (2017)

Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity
por: Olier, Maïwenn, et al.
Publicado: (2012)

Functional investigation of the chromosomal ccdAB and hipAB operon in Escherichia coli Nissle 1917
por: Xu, Jun, et al.
Publicado: (2020)

Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917
por: Dusek, Otakar, et al.
Publicado: (2020)

A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917
por: Nougayrède, Jean-Philippe, et al.
Publicado: (2021)

E. coli Nissle 1917 modulates host glucose metabolism without directly acting on glucose
por: Chavkin, Theodore A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i1siircq93k6c7tlf89uu92anb